Summarizing, based on the re‐analysis of secretome data, we could identify collagen I, collagen IV, and fibronectin as ECM components affecting cisplatin sensitivity, while modulating migratory and adhesive capacity of GCT cells. The gene discussed is FN1; the disease is granular cell tumor.